Lobbying

Elusys Theraputics's latest lobbying report covers Q2 2026, at $19K. The four quarters Q3 2025–Q2 2026 total $197K. Its first report covers Q2 2024; the issues it reports most are Health Issues.

Elusys Theraputics

Latest quarter
$19K
Q2 2026 · 1 reports
Last 12 months
$197K
Last 4 quarters
vs last quarter
−86.4%
Q2 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Elusys Theraputics lobbying by quarter
Elusys Theraputics lobbying by quarter
QuarterAmountReports
Q2 2024$01
Q3 2024$19K1
Q4 2024$19K1
Q1 2025$19K1
Q2 2025$25K1
Q3 2025$19K1
Q4 2025$19K1
Q1 2026$140K1
Q2 2026$19K1

Policy issues the reports name

  • Health issues8 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE5 reports

Firms it paid

Firm
Horizons Global Solutions$279K9 quarters

Former officials lobbying for it

Former position
DAVID FORREST LASSETERFormer Congressional Aide (U.S. House), Former Schedule C (DOD and DOJ)Q2 2026
JULIE LASSETERFormer Schedule C (DOD), Former Congressional Aide (U.S. House, U.S. Senate)Q2 2026
STEPHEN ELLIOTT BOYDAssistant Attorney General at Department of Justice; former Congressional Aide (House and Senate).Q2 2026

Lobbying reports

Filed by
07/13for Q2Horizons Global Solutions$19K
04/08for Q1Horizons Global Solutions$140K
02/10for Q4 2025Horizons Global Solutions$19K
02/10for Q4 2025Horizons Global Solutions$19K
01/08for Q4 2025Horizons Global Solutions$19K
25/10/09for Q3 2025Horizons Global Solutions$19K
25/07/11for Q2 2025Horizons Global Solutions$25K
25/04/16for Q1 2025Horizons Global Solutions$19K
25/01/15for Q4 2024Horizons Global Solutions$19K
24/10/16for Q3 2024Horizons Global Solutions$19K
24/07/12for Q2 2024Horizons Global SolutionsUnder $5,000
24/06/03for Q2 2024Horizons Global SolutionsUnder $5,000